Loading
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (2 ops.)
Latest filing published 15 Sept 2026 for Immunome Inc., €21k. Read the official filing
Filing timeline
BuySaleJack Higgins
Insider track record
Disclosed buys
0
Disclosed sells
2
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Jack Higgins: trading record in brief
Jack Higgins appears in our data through filings on Immunome Inc. shares, published by SEC (Form 4). Between 15 August 2024 and 11 September 2026, the trades on record add up to 10 filings.
No open-market purchase appears, only 2 sales worth €465k. The rest of the record consists of 1 share grant and 4 option exercises. So far in 2026, the count stands at no purchases and 2 sales.
The latest filing, published on 15 September 2026, reports an open-market sale of €288k in Immunome Inc. The median gap between a trade and its publication by SEC (Form 4) is 4 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Jack Higgins
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations10 total
18,000 shares@ US$1.35Common StockSEC:0001993684-26-000008:0
13,200 shares@ US$25.32Common StockSEC:0001993684-26-000008:1
8,800 shares0Common StockSEC:0001993684-26-000008:2
38,250 shares0Common StockSEC:0001993684-26-000006:0
9,438 shares@ US$21.6485.3% of flowCommon StockSEC:0001993684-26-000004:0
6,291 shares0Common StockSEC:0001993684-26-000002:0
1,000 shares0Common StockSEC:0001993684-25-000004:0
22,000 shares@ US$1.3510.9% of flowCommon StockSEC:0001415889-25-024319:0
5,200 shares@ US$1.3521.4% of flowCommon StockSEC:0001415889-25-009201:0
19,524 shares@ US$1.3578.6% of flowCommon StockSEC:0001415889-24-021656:0
10 of 10 declarations
